文献速递其他结缔组织病

心脏与系统性硬化症:一项全国队列研究的发现

Heart and systemic sclerosis-findings from a national cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

该研究基于法国系统性硬化症全国数据库的多中心前瞻性数据,纳入3528例患者,312例(10.9%)基线存在系统性硬化症相关心脏受累;在1646例可随访患者中,系统性硬化症相关心脏受累与死亡风险升高相关,弥漫型亚型和女性性别分别为不同心脏结局的风险因素。

要点

  • 3528例系统性硬化症患者中312例(10.9%)基线存在系统性硬化症相关心脏受累。
  • 可随访的1646例中,系统性硬化症相关心脏受累与死亡风险升高相关。
  • 弥漫型亚型是系统性硬化症相关心脏受累和心包炎的风险因素。

核心结论

  • 研究在大规模人群中描述了系统性硬化症相关心脏受累的发生率和预后负担,性别和弥漫型系统性硬化症亚型为风险因素。
  • 作者认为进一步分析应评估治疗对这些不同心脏结局的潜在影响。

研究设计与样本

  • 研究使用法国系统性硬化症全国数据库的多中心前瞻性研究数据,纳入3528例系统性硬化症患者,其中1646例可用于随访分析。

主要发现

  • 3528例系统性硬化症患者中,312例(10.9%)基线存在系统性硬化症相关心脏受累。
  • 基线存在系统性硬化症相关心脏受累的患者更倾向于为弥漫型系统性硬化症亚型、临床特征更严重,且心血管风险因素更多。
  • 可随访分析的1646例患者中,系统性硬化症相关心脏受累与死亡风险升高相关。
  • 系统性硬化症相关心脏受累、缺血性心脏病或肺动脉高压之间的总生存率无显著差异。
  • 5年时98例患者发生系统性硬化症相关心脏受累(5年事件率11.15%)。

关键数值与推荐

  • 系统性硬化症相关心脏受累基线患病率为10.9%(312/3528)。
  • 系统性硬化症相关心脏受累5年事件率为11.15%(98例)。
  • 左心室射血分数降低<50%的5年事件率为2.49%。
  • 左心室舒张功能障碍的5年事件率为5.84%。
  • 心包炎5年累积发生率为3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出进一步分析应评估治疗对这些不同心脏结局的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Heart involvement is one of the leading causes of death in SSc. The prevalence of SSc-related cardiac involvement is poorly known. Our objective was to investigate the prevalence and prognosis burden of different heart diseases in a nationwide cohort of patients with SSc. METHODS: We used data from a multicentric prospective study using the French SSc national database. Focusing on SSc-related cardiac involvement, we aimed to determine its incidence and risk factors. RESULTS: Of the 3528 patients with SSc, 312 (10.9%) had SSc-related cardiac involvement at baseline. They tended to have a diffuse SSc subtype more frequently and to have more severe clinical features, and presented more cardiovascular risk factors. From the 1646 patients available for follow-up analysis, SSc-related cardiac involvement was associated with an increased risk of death. There was no significant difference in overall survival between SSc-related cardiac involvement, ischaemic heart disease or pulmonary arterial hypertension. Regarding survival analysis, 98 patients developed SSc-related cardiac involvement at 5 years (5-year event rate 11.15%). Regarding reduced left ventricular ejection fraction <50% and left ventricular diastolic dysfunction, the 5-year event rate was 2.49% and 5.84%, respectively. Pericarditis cumulative incidence at 5 years was 3%. Diffuse SSc subtype was a risk factor for SSc-related cardiac involvement and pericarditis. Female sex was associated with less left ventricular diastolic dysfunction incidence. CONCLUSIONS: Our results describe the incidence and prognostic burden of SSc-related cardiac involvement at a large scale, with gender and diffuse SSc subtype as risk factors. Further analyses should assess the potential impact of treatment on these various cardiac outcomes.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Guédon AF, Carrat F, Mouthon L, et al. Heart and systemic sclerosis-findings from a national cohort study. Rheumatology (Oxford). 2024. PMID: 37944039. doi:10.1093/rheumatology/kead599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。